Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD.
暂无分享,去创建一个
[1] K. Ohlsson,et al. Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity , 1989, Inflammation.
[2] K. Hirata,et al. Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease , 2003, Thorax.
[3] R. Buhl,et al. Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis , 2002, European Respiratory Journal.
[4] W. MacNee,et al. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy. , 2008, Novartis Foundation symposium.
[5] I. Pavord,et al. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. , 2001, Respiratory medicine.
[6] N. Ganguly,et al. Increased nitric oxide production by neutrophils in bronchial asthma. , 2001, The European respiratory journal.
[7] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[8] M. Decramer,et al. The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial Committee. , 2001, The European respiratory journal.
[9] P. Montuschi,et al. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. , 2001, American journal of respiratory and critical care medicine.
[10] J. Bargon,et al. Glutathione in induced sputum of healthy individuals and patients with asthma , 2001, Thorax.
[11] J. Steurer,et al. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. , 2000, The European respiratory journal.
[12] H. Magnussen,et al. Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[13] W. MacNee,et al. Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. , 1999, American journal of respiratory and critical care medicine.
[14] C. Cross,et al. Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[15] F. Kelly,et al. Measurement of antioxidants, oxidants and oxidant products in bronchoalveolar lavage fluid. , 1999 .
[16] M. Grisham,et al. Superoxide released from neutrophils causes a reduction in nitric oxide gas. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[17] Kanazawa,et al. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[18] J. Stamler,et al. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure , 1998, The Lancet.
[19] A. Sinclair,et al. Glutathione: in sickness and in health , 1998, The Lancet.
[20] F. Hargreave,et al. Induced sputum cell and fluid-phase indices of inflammation: comparison of treatment with dithiothreitol vs phosphate-buffered saline. , 1997, The European respiratory journal.
[21] S. Tannenbaum,et al. The chemistry of the S-nitrosoglutathione/glutathione system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[22] D G Altman,et al. Statistics notes: Transformations, means, and confidence intervals , 1996, BMJ.
[23] W. MacNee,et al. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. , 1996, Thorax.
[24] J. Stamler,et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[25] L. Smith,et al. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. , 1993, The American review of respiratory disease.
[26] R. Crystal. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. , 1991, The American journal of medicine.
[27] R. Crystal,et al. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis , 1991, The Lancet.
[28] W. MacNee,et al. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. , 1991, Thorax.
[29] R. Crystal,et al. SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS , 1989, The Lancet.
[30] R. Crystal,et al. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. , 1989, The American review of respiratory disease.
[31] R. Crystal,et al. Normal alveolar epithelial lining fluid contains high levels of glutathione. , 1987, Journal of applied physiology.